The trial will see healthy volunteers infected with dengue to test the impact of AbViro’s monoclonal antibody therapy.

The Portuguese Ministry of Health has confirmed the presence of dengue in Madeira, raising concerns among residents and ...

Biological scientists from the National University of Singapore (NUS) have uncovered how the dengue virus uses its envelope ...

Researchers have uncovered how the dengue virus uses its envelope protein to hijack human plasmin to enhance transmission.

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help ...

Australian antiviral drug development company Island Pharmaceuticals has completed subject dosing for the phase 2b ...

Biological scientists have uncovered how the dengue virus uses its envelope protein to capture human plasmin from a blood meal to enhance the permeability of the mosquito midgut for infection.